Prostate Cancer - Results from #25500

Automated vs. manual pattern recognition of 3D (1)H MRSI data of patients with prostate cancer - Abstract July 2, 2012

Prevention and Management of Postprostatectomy Sexual Dysfunctions Part 2: Recovery and preservation of erectile function, sexual desire, and orgasmic function - Abstract July 2, 2012

Current role of diethylstilbestrol in the management of advanced prostate cancer - Abstract July 2, 2012

Pathological characteristics of prostate cancer recurrence after radiation therapy: Implications for focal salvage therapy - Abstract July 2, 2012

A close surgical margin after radical prostatectomy is an independent predictor of recurrence - Abstract July 2, 2012

Outcome predictors of radical prostatectomy followed by adjuvant androgen deprivation in patients with clinical high risk prostate cancer and pT3 surgical margin positive disease - Abstract July 2, 2012

The emerging role of circulating tumor cell detection in genitourinary cancer - Abstract July 2, 2012

Preoperative estimated glomerular filtration rate predicts overall mortality in patients undergoing radical prostatectomy - Abstract July 2, 2012

When to perform bone scan in patients with newly diagnosed prostate cancer: External validation of a novel risk stratification tool - Abstract June 30, 2012

Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen - Abstract June 30, 2012

A spotlight from prostate cancer - Abstract June 30, 2012

Prevention and Management of Postprostatectomy Sexual Dysfunctions Part 1: Choosing the right patient at the right time for the right surgery - Abstract June 30, 2012

Elastic image registration for guiding focal laser ablation of prostate cancer: Preliminary results - Abstract June 30, 2012

Morbidity and costs of salvage vs. primary radical prostatectomy in older men - Abstract June 30, 2012

The characteristics of bladder cancer after radiotherapy for prostate cancer - Abstract June 30, 2012

Ultrasound-guided transperineal 24-core saturation prostate biopsy is superior to the 14-core scheme in detecting prostate cancer in patients with PSA less than 20 microg/L - Abstract June 29, 2012

FDA approves new blood test to improve prostate cancer detection June 29, 2012

Leukopenia as a risk factor for osteonecrosis of the jaw in metastatic prostate cancer treated using zoledronic acid and docetaxel - Abstract June 29, 2012

Long-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer - Abstract June 29, 2012

A specific molecular beacon probe for the detection of human prostate cancer cells - Abstract June 29, 2012

Page 1276 of 1436